This presentation offers an overview of HIV vaccine research in Africa. It describes major networks, their location and ongoing studies as of October 2014. It also introduces issues with various regulatory frameworks that can affect the conduct of clinical research.
This presentation was given as part of a community education event organised by AVAC, NAM and AHPN following a proposal by Bisi Alimi. The event introduced vaccines, current state of the research and the difficulties to develop an efficient HIV vaccine. The purpose of the presentation below was to go beyond the science and put vaccine development in the broader context of product manufacturing and legal and regulatory frameworks.
This presentation is a short introduction to project management for researchers and clinicians. It provides an overview of the process and emphasises some key elements of project management such as the Gannt Chart, how to write milestones and how to approach risk. The presentation was given at the MRCC as apart of a Workshop for applicants to the DPFS/DCS scheme.
Key stages of the Universal Test and Treat approach and linkage to care for HIV prevention.
HIV-negative individuals remain in the system and receive further counselling whilst HIV-positive are linked to care where they receive continuous attention and support to achieve viral suppression. Top: weaknesses and threats faced by the approach. Bottom: strengths and opportunities to address the challenges of delivering ART in a variety of contexts building on existing resources and “know-how” and developing new approaches to solve systemic problems.
Download as a PDF: TasP Continuum of Care 1
Treatment for Prevention stands at the epicentre of a number of services. It can only succeed by being part of a whole.
Download as a PDF: TasP Continuum of Care 2
The conduct of clinical research often conflicts with community life even if it is done for the benefit of the public. This can be explained by differences in perception, understanding and respective knowledge of each other’s interests and needs. This slide was designed to support discussions around the issues raised by the need to conduct clinical research in communities which often struggle to undertsand the research and how they can impact on what is being done. It can also be used by communities who want to engage with researchers to facilitate the conduct of mutually beneficial clinical research.
What is good enough? Who decides?
This presentation was prepared for an IRMA global teleconference on December 4, 2009.
FROM KAMPALA TO CAPE TOWN A Journey on the HIV Vaccine Networks Highway
The Search for an HIV Vaccine: Why does it take so long?
From Bench to Clinic: A Researchers Guide to Move Candidate Vaccines into Trials
A Brief Introduction to Project Management
Bench to Clinic Roadmap
@B3EXECS @IAVI Did you get to see the data centre? - posted on 22/09/2017
Data centre #umic for @iavi ADVANCE warehouse, state of the art laboratory assay, robots and spare power #uvri https://t.co/4evyXBjsew - posted on 22/09/2017@IAVI These are two different gel imager to take picture of electrophoresis gel https://t.co/QnKpigCTVx - posted on 22/09/2017
@B3EXECS The close-up of the device labeled “Bio Rad.” - posted on 22/09/2017@IAVI Second raw bottom or top right? - posted on 22/09/2017